RhumbLine Advisers’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

RhumbLine Advisers’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-124,022	Closed	-$2.23M	–	3077
2020 Q2	$2.23M	Buy	124,022 +14,387	+13%	+$259K	﹤0.01%	1669
2020 Q1	$782K	Buy	109,635 +1,171	+1%	+$8.35K	﹤0.01%	1988
2019 Q4	$2.59M	Buy	108,464 +9,601	+10%	+$229K	﹤0.01%	1658
2019 Q3	$2.65M	Buy	98,863 +6,426	+7%	+$172K	﹤0.01%	1574
2019 Q2	$2.51M	Buy	92,437 +5,442	+6%	+$148K	﹤0.01%	1600
2019 Q1	$3.02M	Sell	86,995 -967	-1%	-$33.6K	0.01%	1472
2018 Q4	$1.72M	Buy	87,962 +28,632	+48%	+$559K	﹤0.01%	1732
2018 Q3	$1.58M	Sell	59,330 -3,730	-6%	-$99.3K	﹤0.01%	1778
2018 Q2	$2.38M	Buy	63,060 +8,948	+17%	+$338K	﹤0.01%	1578
2018 Q1	$1.77M	Sell	54,112 -770	-1%	-$25.1K	﹤0.01%	1677
2017 Q4	$2.67M	Sell	54,882 -9,807	-15%	-$477K	0.01%	1458
2017 Q3	$3.5M	Buy	64,689 +7,210	+13%	+$390K	0.01%	1254
2017 Q2	$3.23M	Sell	57,479 -670	-1%	-$37.6K	0.01%	1272
2017 Q1	$2.28M	Buy	58,149 +3,097	+6%	+$121K	0.01%	1475
2016 Q4	$1.24M	Buy	55,052 +1,411	+3%	+$31.7K	﹤0.01%	1739
2016 Q3	$1.22M	Sell	53,641 -350	-0.6%	-$7.95K	﹤0.01%	1709
2016 Q2	$1.27M	Buy	53,991 +2,041	+4%	+$48.2K	﹤0.01%	1638
2016 Q1	$1.06M	Buy	51,950 +2,580	+5%	+$52.6K	﹤0.01%	1750
2015 Q4	$2.54M	Buy	49,370 +7,075	+17%	+$364K	0.01%	1200
2015 Q3	$1.8M	Sell	42,295 -100	-0.2%	-$4.26K	0.01%	1387
2015 Q2	$1.93M	Buy	42,395 +1,645	+4%	+$74.9K	0.01%	1435
2015 Q1	$1.55M	Buy	40,750 +7,695	+23%	+$292K	﹤0.01%	1569
2014 Q4	$936K	Buy	33,055 +3,530	+12%	+$100K	﹤0.01%	1862
2014 Q3	$746K	Sell	29,525 -1,200	-4%	-$30.3K	﹤0.01%	1953
2014 Q2	$897K	Buy	30,725 +22,544	+276%	+$658K	﹤0.01%	1900
2014 Q1	$212K	Sell	8,181 -470	-5%	-$12.2K	﹤0.01%	2738
2013 Q4	$223K	Buy	8,651 +210	+2%	+$5.41K	﹤0.01%	2764
2013 Q3	$226K	Sell	8,441 -9	-0.1%	-$241	﹤0.01%	2711
2013 Q2	$208K	Buy	+8,450	New	+$208K	﹤0.01%	2960